Tibet AIM Pharm. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	433.56	537.66	427.4	385.86	321.28	182.73
Trading Asset Securities	200	-	-	-	-	-
Cash & Short-Term Investments	633.56	537.66	427.4	385.86	321.28	182.73
Cash Growth	28.63%	25.80%	10.77%	20.10%	75.83%	-11.00%
Accounts Receivable	25.77	29.53	52.37	38.29	169.96	44.24
Other Receivables	2.29	2.62	2.97	5.37	31.91	93.17
Receivables	28.06	32.15	55.34	43.66	201.87	137.4
Inventory	57.43	59.78	41.05	58.97	45.55	33.61
Prepaid Expenses	-	-	-	-	-	3.29
Other Current Assets	4.22	4.08	3.82	1.19	6.3	5.14
Total Current Assets	723.27	633.68	527.61	489.67	575.01	362.17
Property, Plant & Equipment	327.51	331.3	344.63	349.15	364.85	378.96
Long-Term Investments	3.48	3.53	3.62	42.57	-	-
Goodwill	16.67	16.67	16.67	16.67	36.47	36.47
Other Intangible Assets	19.01	19.2	20.7	25.91	31.1	37.25
Long-Term Deferred Tax Assets	3.87	3.84	2	3.51	4.81	2.13
Long-Term Deferred Charges	-	-	-	-	1.78	3.57
Other Long-Term Assets	9.49	9.45	11.24	0.26	4.18	3.92
Total Assets	1,103	1,018	926.47	927.74	1,018	824.47
Accounts Payable	145.23	105.83	103.51	106.04	127.01	17.2
Accrued Expenses	26.42	25.66	18.98	14.71	27.23	18.56
Short-Term Debt	-	11.26	22.82	11.01	50.05	-
Current Income Taxes Payable	11.88	9.32	1.87	1.48	4.74	1.4
Current Unearned Revenue	5.42	1.95	3.15	3.51	4.21	9.24
Other Current Liabilities	71.52	42.66	24.78	34.33	48.67	52.94
Total Current Liabilities	260.46	196.68	175.12	171.08	261.91	99.35
Long-Term Unearned Revenue	4.81	4.97	5.78	6.6	4.43	5.02
Other Long-Term Liabilities	-	-	-	-	1.86	-
Total Liabilities	265.27	201.65	180.89	177.68	268.21	104.36
Common Stock	190.68	190.68	190.68	190.68	190.68	191.19
Additional Paid-In Capital	244.08	232.64	232.66	232.66	232.68	234.49
Retained Earnings	452.11	432.46	358.61	318.28	321.96	296.83
Treasury Stock	-57.35	-48.15	-50.03	-	-0.02	-5.12
Comprehensive Income & Other	8.49	8.39	7.08	3.4	-0.01	-0
Total Common Equity	838.02	816.02	739	745.02	745.29	717.39
Minority Interest	-	-	6.57	5.04	4.7	2.72
Shareholders' Equity	838.02	816.02	745.58	750.06	750	720.11
Total Liabilities & Equity	1,103	1,018	926.47	927.74	1,018	824.47
Total Debt	-	11.26	22.82	11.01	50.05	-
Net Cash (Debt)	633.56	526.41	404.58	374.85	271.23	182.73
Net Cash Growth	38.57%	30.11%	7.93%	38.20%	48.44%	10.53%
Net Cash Per Share	3.47	2.84	2.20	1.95	1.41	0.95
Filing Date Shares Outstanding	178.62	183.17	183.47	190.68	190.68	191.19
Total Common Shares Outstanding	178.62	183.17	183.47	190.68	190.68	191.19
Working Capital	462.81	437	352.5	318.59	313.1	262.83
Book Value Per Share	4.69	4.46	4.03	3.91	3.91	3.75
Tangible Book Value	802.35	780.15	701.64	702.44	677.72	643.67
Tangible Book Value Per Share	4.49	4.26	3.82	3.68	3.55	3.37
Buildings	-	-	349.96	350.18	350.18	350.18
Machinery	-	-	106.93	96.49	96.82	92.61
Construction In Progress	-	-	-	-	-	2.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.